Good Doctor·Hyperthermic Perfusion | The First Session of Standardized Clinical Application Training for Hyperthermic Perfusion Therapy Machines in 2026 Concludes Successfully
From March 21 to 22, 2026, the first session of the 2026 Standardized Clinical Application Training on GD Hyperthermic Perfusion Therapy Devices successfully concluded. Medical professionals and partners from across the country gathered to enhance their skills through learning and to drive improvement through exchange, thereby injecting new momentum into the standardized development of hyperthermic perfusion therapy for cancer.
2026-03-22
From March 21 to 22, 2026, the first session of the 2026 Standardized Clinical Application Training on GD Hyperthermic Perfusion Therapy Devices successfully concluded. Medical professionals and partners from across the country gathered to enhance their skills through learning and exchange, thereby injecting new momentum into the standardized development of hyperthermic perfusion therapy for cancer.
This training session thoroughly implements the concept of synergistically advancing medical technology innovation and standardized clinical application at Xi’an Good Doctor. A team of instructors has been specially assembled, comprising senior industry experts and key frontline clinicians. Leveraging the company’s years of technological accumulation and extensive clinical experience, the training provides detailed explanations on equipment operation standards, handling of common problems, and clinical application techniques, while also sharing the latest clinical cases and application outcomes of this technology in cancer diagnosis and treatment, thereby helping participants quickly master core knowledge and practical skills.
During the training, medical professionals and partners demonstrated exceptional enthusiasm, attentively listening and actively engaging in interactive discussions. They delved deeply into the challenges and uncertainties encountered in clinical practice, creating a vibrant yet well-organized atmosphere on site. Following systematic instruction and rigorous assessment, all participants successfully completed the training program, passed the evaluation with flying colors, and were awarded certificates of completion—thus fully achieving the training objectives of “gaining knowledge through learning, mastering skills through practice, and passing assessments through examination.”
Xi’an Good Doctor Medical has consecutively hosted numerous standardized training and academic exchange events, continuously delving into the industry, providing long-term support for clinical practice, and contributing to the high-quality development of the oncology diagnosis and treatment field.
In the future, Xi’an Good Doctor Medical will continue to stay true to its original aspiration, focus on technological innovation and clinical needs, work with medical professionals and partners, promote hyperthermic intraperitoneal chemotherapy for cancer treatment, and make greater contributions to the steady progress of cancer diagnosis and treatment in China.
Key words:
Related News







